Drugs / gp100-fowlpox vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00085462 | May 2004 → May 2007 | cutaneous melanoma | National Institutes of Health Clinical Center (CC) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gp100-fowlpox vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00085462 ↗ |
| Modality | Vaccine | “fowlpox-gp100 vaccine” NCT00085462 ↗ |
| Route | Intravenous | “fowlpox-gp100 vaccine (before TIL/PBL infusion) IV over 1-2 minutes” NCT00085462 ↗ |